{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:06Z","timestamp":1787440926631,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007052","name":"University of Verona","doi-asserted-by":"publisher","award":["FUR2024"],"award-info":[{"award-number":["FUR2024"]}],"id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijantimicag.2026.107877","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:42:21Z","timestamp":1780674141000},"page":"107877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emergence of dalbavancin non-susceptible methicillin-resistant Staphylococcus epidermidis (MRSE) in a patient treated with dalbavancin prolonged therapy: Case report, therapeutic drug monitoring and genomic characterization"],"prefix":"10.1016","volume":"67","author":[{"given":"Simone","family":"Giuliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PierGiorgio","family":"Cojutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Bulfoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cotrufo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Curcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolo","family":"Gualandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Moreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tascini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gaibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107877_bib0001","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41579-022-00780-3","article-title":"Staphylococcus epidermidis and its dual lifestyle in skin health and infection","volume":"21","author":"Severn","year":"2023","journal-title":"Nat Rev Microbiol."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0002","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrmicro2182","article-title":"Staphylococcus epidermidis \u2014 the \u2018accidental\u2019 pathogen","volume":"7","author":"Otto","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0003","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/CMR.00109-13","article-title":"Coagulase-negative staphylococci","volume":"27","author":"Becker","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0004","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/s41564-018-0230-7","article-title":"Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis","volume":"3","author":"Lee","year":"2018","journal-title":"Nat Microbiol."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41579-018-0019-y","article-title":"Implant infections: adhesion, biofilm formation and immune evasion","volume":"16","author":"Arciola","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0006","first-page":"417","article-title":"Significance of coagulase-negative staphylococci in healthcare-associated infections","volume":"22","author":"Widerstr\u00f6m","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0007","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.idc.2008.10.001","article-title":"Coagulase-negative staphylococcal infections","volume":"23","author":"Rogers","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0008","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijmm.2014.04.013","article-title":"The role of Staphylococcus epidermidis in neonatal sepsis: guarding angel or pathogenic devil?","volume":"304","author":"Dong","year":"2014","journal-title":"Int J Med Microbiol."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0009","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for Healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0010","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.3389\/fmicb.2018.02723","article-title":"Factors contributing to the evolution of mecA-mediated \u03b2-lactam resistance in Staphylococci: update and new insights from whole genome sequencing (WGS)","volume":"9","author":"Miragaia","year":"2018","journal-title":"Front Microbiol."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0011","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/bies.201200112","article-title":"Coagulase-negative staphylococci as reservoirs of genes facilitating MRSA infection: staphylococcal commensal species such as Staphylococcus epidermidis are being recognized as important sources of genes promoting MRSA colonization and virulence","volume":"35","author":"Otto","year":"2013","journal-title":"Bioessays."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0012","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijantimicag.2017.11.008","article-title":"Dalbavancin in the treatment of different gram-positive infections: a real-life experience","volume":"51","author":"Bouza","year":"2018","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0013","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s10096-024-04849-0","article-title":"Dalbavancin as suppressive therapy for implant-related infections: a case series with therapeutic drug monitoring and review of the literature","volume":"43","author":"Lafon-Desmurs","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0014","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tim.2009.11.005","article-title":"Exploring innate glycopeptide resistance mechanisms in Staphylococcus aureus","volume":"18","author":"Renzoni","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0015","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in staphylococci","volume":"124","author":"Gardete","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae163","article-title":"Dalbavancin-resistant Staphylococcus epidermidis in vivo selection following a prosthetic joint infection: phenotypic and genomic characterization","volume":"6","author":"Ruffier d\u2019Epenoux","year":"2024","journal-title":"JAC Antimicrob Resist."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0017","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0018","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/cid\/ciac341","article-title":"Emergence of dalbavancin, vancomycin, and daptomycin nonsusceptible Staphylococcus aureus in a patient treated with dalbavancin: case report and isolate characterization","volume":"75","author":"Zhang","year":"2022","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0019","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jgar.2025.12.010","article-title":"Multicentric evaluation of the MTS\u2122 Synergy Application System for reliable antibiotic synergy testing in clinical laboratories","volume":"46","author":"Carretto","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106445","article-title":"Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of- concept","volume":"58","author":"Cojutti","year":"2021","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01830-24","article-title":"Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections","volume":"69","author":"Cojutti","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0022","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.jchromb.2011.07.027","article-title":"Dalbavancin: quantification in human plasma and urine by a new improved high performance liquid chromatography-tandem mass spectrometry method","volume":"879","author":"Alebic-Kolbah","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0023","first-page":"322","article-title":"In vitro activity of cefepime\/enmetazobactam and cefepime\/zidebactam against OXA-48-producing Klebsiella pneumoniae clinical strains","volume":"48","author":"Bulfoni","year":"2025","journal-title":"New Microbiol"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107877_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42755","article-title":"Prophages in Bacteroides fragilis: distribution and genetic diversity","volume":"11","author":"Gaibani","year":"2025","journal-title":"Heliyon."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0025","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/jac\/dkac100","article-title":"Dynamic evolution of imipenem\/relebactam resistance in a KPC- producing Klebsiella pneumoniae from a single patient during ceftazidime\/avibactam-based treatments","volume":"77","author":"Gaibani","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01743-18","article-title":"Dalbavancin alone and in combination with ceftaroline against four different phenotypes of Staphylococcus aureus in a simulated pharmacodynamic\/pharmacokinetic model","volume":"63","author":"Kebriaei","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0027","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.3390\/ijms23158088","article-title":"Molecular mechanisms of drug resistance in Staphylococcus aureus","volume":"23","author":"Mlynarczyk-Bonikowska","year":"2022","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0028","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in staphylococci","volume":"124","author":"Gardete","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.116132","article-title":"Case report: prosthetic aortic valve endocarditis due to Staphylococcus epidermidis with acquired resistance in the walK gene","volume":"108","author":"Cepeda","year":"2024","journal-title":"Diagn Microbiol Infect Dis."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0030","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/dkac434","article-title":"Emerging resistance in Staphylococcus epidermidis during dalbavancin exposure: a case report and in vitro analysis of isolates from prosthetic joint infections","volume":"78","author":"Al Janabi","year":"2023","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0031","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","article-title":"Antibiotic resistance of bacteria in biofilms","volume":"358","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0032","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/antibiotics11080996","article-title":"Population pharmacokinetic and pharmacodynamic analysis of dalbavancin for long-term treatment of subacute and\/or chronic infectious diseases: the major role of therapeutic drug monitoring","volume":"11","author":"Cojutti","year":"2022","journal-title":"Antibiotics (Basel)."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0033","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00094-16","article-title":"Population genomics of reduced vancomycin susceptibility in Staphylococcus aureus","volume":"1","author":"Rishishwar","year":"2016","journal-title":"mSphere."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0034","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1073\/pnas.0609839104","article-title":"Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing","volume":"104","author":"Mwangi","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0035","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/AAC.00209-07","article-title":"Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus","volume":"51","author":"Meehl","year":"2007","journal-title":"Antimicrob Agents Chemother."},{"issue":"12","key":"10.1016\/j.ijantimicag.2026.107877_bib0036","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/antibiotics9120865","article-title":"In vitro activity of Dalbavancin against refractory multidrug-resistant (MDR) Staphylococcus aureus isolates","volume":"9","author":"Bongiorno","year":"2020","journal-title":"Antibiotics (Basel)."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0037","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/JCM.02144-10","article-title":"Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus","volume":"49","author":"Watanabe","year":"2011","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0038","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1186\/s12879-024-09797-w","article-title":"Unraveling novel mutation patterns and morphological variations in two dalbavancin-resistant MRSA strains in Austria using whole genome sequencing and transmission electron microscopy","volume":"24","author":"Hotz","year":"2024","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0039","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.cmi.2017.07.028","article-title":"Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen","volume":"24","author":"Werth","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0040","doi-asserted-by":"crossref","first-page":"910.e1","DOI":"10.1016\/j.cmi.2020.08.025","article-title":"Dalbavancin exposure in vitro selects for dalbavancin- non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus","volume":"27","author":"Werth","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0041","first-page":"e02260","article-title":"Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections","volume":"65","author":"Cojutti","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0042","first-page":"82","article-title":"Evaluation of dalbavancin alone and in combination with \u03b2-lactam antibiotics against resistant phenotypes of Staphylococcus aureus","volume":"74","author":"Xhemali","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107877_bib0043","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1093\/jac\/dkaf262","article-title":"Paradoxical interaction between dalbavancin and \u03b2-lactams against endocarditis-associated Enterococcus faecalis clinical isolates","volume":"80","author":"Luque Paz","year":"2025","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:41:54Z","timestamp":1787438514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926001597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0924857926001597"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107877","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of dalbavancin non-susceptible methicillin-resistant Staphylococcus epidermidis (MRSE) in a patient treated with dalbavancin prolonged therapy: Case report, therapeutic drug monitoring and genomic characterization","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107877"}}